S03 E09
Surgibots Podcast

Flexibility, Accessibility, Simplicity: Dexter’s Approach to Robotics - Greg Roche – Distalmotion

Take a look at the inner workings of Distalmotion with CEO Greg Roche and your host, Henry Norton, in this fascinating episode! Greg shared the importance of the company’s value proposition in taking Dexter, their surgical robot, to a global market. They also touched on the evolution of surgical robotics, both in technical terms and its increasing adoption in new generations of surgeons. Tune in to discover more about innovation in smaller surgical robotics players.

Flexibility, Accessibility, Simplicity: Dexter’s Approach to Robotics - Greg Roche – Distalmotion

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
S03 E09

Flexibility, Accessibility, Simplicity: Dexter’s Approach to Robotics - Greg Roche – Distalmotion

The Future of Surgical Robotics: Innovations, Market Growth, and Accessibility

The field of surgical robotics is experiencing a significant transformation, driven by advancements in technology, increased accessibility, and a growing demand for minimally invasive procedures. In a recent conversation with Greg Roche, an industry leader with extensive experience in surgical robotics, we explored the evolution of robotic-assisted surgery, commercialization strategies, and the future of the industry.

The Evolution of Surgical Robotics

Greg Roche, who has had a dynamic career spanning major med-tech companies, highlighted the evolution of surgical robotics from its early days to its current state. He explained how companies like Zimmer Biomet, Stryker, and DigitalOcean have contributed to shaping the market, bringing robotic-assisted surgical systems to orthopedic and soft tissue surgeries.

One of the key takeaways from Roche's journey was the importance of identifying the true value of robotic systems. While orthopedic and laparoscopic surgeries have traditionally been performed by highly skilled surgeons, robotics has introduced new efficiencies, improved precision, and enhanced patient outcomes.

Commercialization Strategies: Lessons from Market Leaders

Launching a surgical robot in a competitive market requires a well-defined commercialization strategy. Roche shared insights from his time at Zimmer Biomet and Avatara Medical, where he led product launches and expansion efforts. Some key strategies for successful commercialization include:

  • Strong Product Development: A high-quality, reliable robotic system is crucial. The conversion of neuro-robotic technology to orthopedic applications at Zimmer Biomet exemplifies the importance of a strong R&D team.

  • Market Positioning: Understanding the value proposition and ensuring the product solves a real problem for surgeons is essential.

  • Strategic Expansion: Companies must be deliberate in selecting their market entry points, balancing growth with sustainability.

  • Accessibility and Cost-Effectiveness: Making robotic surgery financially and logistically viable for hospitals and outpatient centers is a key differentiator.

The Shift Towards Outpatient Surgery Centers

One of the most significant trends in surgical robotics is the shift from traditional hospitals to outpatient surgery centers (ASC). Roche emphasized that these centers offer a better experience for both patients and physicians. Benefits include:

  • Efficiency: Faster turnaround times and streamlined processes.

  • Cost Reduction: Lower operational costs compared to large hospital systems.

  • Improved Patient Experience: More convenient and less invasive procedures.

Companies like DistalMotion, where Roche currently serves in a leadership role, are focusing on making robotic surgery more accessible in these settings. Dexter, their flagship surgical robot, is designed to integrate seamlessly into a surgeon’s workflow while maintaining affordability and flexibility.

Competitive Landscape and Market Expansion

The surgical robotics market has long been dominated by a few key players, but emerging companies are now challenging the status quo. With new market entrants securing FDA clearances, competition is heating up. Roche believes that this increase in competition will drive further innovation and provide hospitals with more options, ultimately benefiting patients.

Furthermore, mergers and acquisitions (M&A) are playing a significant role in shaping the industry. Larger medical device companies are looking to acquire smaller, innovative firms to bolster their robotic surgery portfolios. This trend is expected to continue as demand for robotic-assisted procedures grows.

The Future of Surgical Robotics

Looking ahead, the field of surgical robotics is poised for significant expansion. Several factors will drive this growth, including:

  • Geographic Expansion: More hospitals and surgical centers globally will adopt robotic systems.

  • Increased Adoption in New Surgical Procedures: Robotics will be applied to a wider range of surgeries beyond orthopedics and general surgery.

  • Advancements in AI and Data Science: Machine learning and data analytics will enhance the capabilities of robotic systems, improving patient outcomes.

  • Training and Education: Medical schools and residency programs are incorporating robotic training, ensuring the next generation of surgeons is proficient in robotic-assisted procedures.

Surgical robotics is not just a trend; it is the future of healthcare. With continued innovation, improved accessibility, and increased adoption, robotic-assisted surgery is set to revolutionize the way surgical procedures are performed. Companies like DistalMotion are leading the charge, ensuring that high-quality surgical robotics technology is available to more healthcare providers and patients worldwide.

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

More episodes in this industry

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental
Podcast41

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental

Join host Henry Norton in this episode of The Crux of Medtech as he speaks to Paul Roberts, co-founder of CMR Surgical and current CEO of Lupin Dental. Paul shares the journey from building surgical robots in a former pig shed to co-founding one of the most recognised names in robotic surgery. Now, he’s applying that experience to an entirely new frontier, aesthetic dental robotics. In this episode, Paul explains why dental veneers are about more than vanity, how robotic precision can eliminate outdated practices like tooth stumping, and why Lupin’s tech could completely transform smile restoration. He also opens up about his medtech philosophy, including why engineers shouldn’t build products alone, and what it really takes to move from zero to launch in a capital-intensive field like robotics. Key Topics Why Paul left surgical robotics for dental robotics The founding story of CMR Surgical The clinical and aesthetic importance of veneers How Lupin reduces a 5-visit dental process into 1 What medtech can learn from AlignTech and Invisalign Building a profitable robot company without hundreds of millions Related Insights Crowns are outdated. Robotic veneers restore enamel with less damage Engineers alone don’t make great products clinicians must co-create One robotic session at Lupin replaces five traditional dental visits India is a strategic first market and a smart regulatory play Fail fast, but never compromise on patient safety Core Challenges Tooth restoration has long been inefficient: dentists rely on hand-guesswork for shaping and prepping teeth. It’s a manual, error-prone process that requires multiple appointments and can cause long-term sensitivity. Lupin Dental solves this with AI-powered planning, CAD design, and a precision robot that prepares the tooth and bonds the veneer all in one session. Tune in now to hear how surgical-grade robotics are reshaping the smile economy and why Lupin Dental could be the next CMR.
Artificial Intelligence Feels Like Magic - With Peter Verrillo
Podcast40

Artificial Intelligence Feels Like Magic - With Peter Verrillo

Meet Peter Verrillo, the CEO of Redefine Surgery. He joins your host, Henry Norton, in this episode to discuss the latest developments in orthopaedic AI. Throughout the conversation, Peter highlights how time-consuming knee surgery can be, and talks about the AI solutions that his company is creating to reduce the time spent in theatre. Peter also shares his journey as a founder of multiple different companies, touching on everything from funding and acquisitions to building prototypes in his basement. He also emphasises the benefits of working with device-manufacturing companies, as they will take his AI to market under a whitelabel. He states that this relationship is a key part of the medtech industry. Peter also touches on the importance of strong sales reps, suggesting that they should have training in both the software and robotics sides of this new technology in order to efficiently translate it to surgeons.

Discover more about Medical Devices